These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 14057639)

  • 41. [Present-day problems of metabolic tubular syndromes].
    PACOVSKY V; DUBOVSKY J
    Cas Lek Cesk; 1963 Jan; 102():57-61. PubMed ID: 13940990
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute tubular necrosis and its management.
    HOLMES JH
    Surg Clin North Am; 1963 Apr; 43():555-68. PubMed ID: 13961408
    [No Abstract]   [Full Text] [Related]  

  • 43. An unusual cause of severe kidney tubular dysfunction: Questions.
    Takase HM; de Freitas Segredo MP; Pereira LMS; Riyuzo MC
    Pediatr Nephrol; 2022 Jun; 37(6):1307-1308. PubMed ID: 35006353
    [No Abstract]   [Full Text] [Related]  

  • 44. An unusual cause of severe kidney tubular dysfunction: Answers.
    Takase HM; de Freitas Segredo MP; Pereira LMS; Riyuzo MC
    Pediatr Nephrol; 2022 Jun; 37(6):1309-1311. PubMed ID: 35006354
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nephrocalcinosis].
    LAGRUE G; FRITEL D; MILLIEZ P
    Rev Prat; 1959 Feb; 9(6):613-4 passim. PubMed ID: 13634806
    [No Abstract]   [Full Text] [Related]  

  • 46. Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996-2020).
    Chan JC; Dear J; Palm C; Reagan K
    J Vet Intern Med; 2023; 37(3):1030-1037. PubMed ID: 37148178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
    Ribeiro TG; Franca JR; Fuscaldi LL; Santos ML; Duarte MC; Lage PS; Martins VT; Costa LE; Fernandes SO; Cardoso VN; Castilho RO; Soto M; Tavares CA; Faraco AA; Coelho EA; Chávez-Fumagalli MA
    Int J Nanomedicine; 2014; 9():5341-53. PubMed ID: 25429219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. INFECTIOUS DISEASES. ANNUAL REVIEW OF SIGNIFICANT PUBLICATIONS.
    REIMANN HA
    Postgrad Med J; 1964 Oct; 40(468):570-89. PubMed ID: 14220404
    [No Abstract]   [Full Text] [Related]  

  • 49. THE TREATMENT OF COCCIDIOIDAL MENINGITIS. THE USE OF AMPHOTERICIN B IN A GROUP OF 25 PATIENTS.
    WINN WA
    Calif Med; 1964 Aug; 101(2):78-89. PubMed ID: 14180502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ion movements in cell injury. Effect of amphotericin B on the ultrastructure and function of the epithelial cells of the toad bladder.
    Saladino AJ; Bentley PJ; Trump BF
    Am J Pathol; 1969 Mar; 54(3):421-66. PubMed ID: 5774265
    [No Abstract]   [Full Text] [Related]  

  • 51. Nephrotoxic drugs.
    Mendoza SA
    Pediatr Nephrol; 1988 Oct; 2(4):466-76. PubMed ID: 3153061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats.
    Longuet P; Joly V; Amirault P; Seta N; Carbon C; Yeni P
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1303-8. PubMed ID: 1929286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distal renal tubular acidosis: the value of urinary pH, PCO2 and NH4+ measurements.
    Wrong O
    Pediatr Nephrol; 1991 Mar; 5(2):249-55. PubMed ID: 1903268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitigation of amphotericin B nephrotoxicity by mannitol.
    Olivero JJ; Lozano-Mendez J; Ghafary EM; Eknoyan G; Suki WN
    Br Med J; 1975 Mar; 1(5957):550-1. PubMed ID: 1095113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys.
    Bullock WE; Luke RG; Nuttall CE; Bhathena D
    Antimicrob Agents Chemother; 1976 Sep; 10(3):555-63. PubMed ID: 791105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NEPHROTOXIC TUBULAR DAMAGE AND CALCIUM DEPOSITION FOLLOWING AMPHOTERICIN B THERAPY.
    WERTLAKE PT; BUTLER WT; HILL GJ; UTZ JP
    Am J Pathol; 1963 Sep; 43(3):449-57. PubMed ID: 14057639
    [No Abstract]   [Full Text] [Related]  

  • 57. AMPHOTERICIN B TOXICITY; CHANGES IN RENAL MORPHOLOGY.
    HILL GJ
    Ann Intern Med; 1964 Aug; 61():349-54. PubMed ID: 14204871
    [No Abstract]   [Full Text] [Related]  

  • 58. AMPHOTERICIN B TOXICITY; CHANGES IN RENAL FUNCTION.
    BUTLER WT
    Ann Intern Med; 1964 Aug; 61():344-9. PubMed ID: 14204870
    [No Abstract]   [Full Text] [Related]  

  • 59. RENAL HISTOPATHOLOGY ASSOCIATED WITH DIFFERENT DEGREES OF AMPHOTERICIN B TOXICITY IN THE DOG.
    WERTLAKE PT; HILL GJ; BUTLER WT
    Proc Soc Exp Biol Med; 1965 Feb; 118():472-6. PubMed ID: 14268656
    [No Abstract]   [Full Text] [Related]  

  • 60. [Metabolic disturbances in renal tubular acidosis; calcium and phosphorus metabolism (kidney calculi and kidney calcinosis)].
    Hiraishi K; Nakamura S; Kurokawa K
    Nihon Rinsho; 1985 Sep; 43(9):1914-8. PubMed ID: 3912552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.